Your browser doesn't support javascript.
loading
Acinic cell carcinoma of the salivary glands: a literature review
Hematology, Oncology and Stem Cell Therapy. 2009; 2 (1): 259-264
en Inglés | IMEMR | ID: emr-91106
ABSTRACT
Acinic cell carcinoma [ACC] is a low-grade malignant salivary neoplasm that constitutes approximately 17% of primary salivary gland malignancies. In the head and neck region, the parotid gland is the preddominant site of origin and women are usually more frequently diagnosed than men. Previous radiation exposure and familial predisposition are some of the risk factors for ACC. A slowly enlarging mass lesion in the tail of the parotid gland is the most frequent presentation. The diagnosis is usually confirmed with a fine needle aspiration biopsy, and surgical excision is the main treatment of this malignant neoplasm. Other treatment modalities such as radiotherapy may be indicated in some cases. ACC has a significant tendency to recur, to produce metastases [cervical lymph nodes and lungs], and may have an aggressive evolution. Therefore, long-term follow-up is mandatory after treatment
Asunto(s)
Buscar en Google
Índice: IMEMR (Mediterraneo Oriental) Asunto principal: Glándula Parótida / Radioterapia / Organización Mundial de la Salud / Neoplasias de la Parótida / Neoplasias de las Glándulas Salivales / Imagen por Resonancia Magnética / Tomografía Computarizada por Rayos X / Factores de Riesgo / Carcinoma de Células Acinares / Biopsia con Aguja Fina Límite: Femenino / Humanos / Masculino Idioma: Inglés Revista: Hematol. Oncol. Stem Cell Ther. Año: 2009

Similares

MEDLINE

...
LILACS

LIS

Buscar en Google
Índice: IMEMR (Mediterraneo Oriental) Asunto principal: Glándula Parótida / Radioterapia / Organización Mundial de la Salud / Neoplasias de la Parótida / Neoplasias de las Glándulas Salivales / Imagen por Resonancia Magnética / Tomografía Computarizada por Rayos X / Factores de Riesgo / Carcinoma de Células Acinares / Biopsia con Aguja Fina Límite: Femenino / Humanos / Masculino Idioma: Inglés Revista: Hematol. Oncol. Stem Cell Ther. Año: 2009